4 Results for "

CPP12

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CPP12" in MCE Product Catalog:

Cat. No.: HY-P10649
CAS No.: 1831064-62-0
Target:  

Peptides

Research Areas:  

Cancer

CPP12 is a small, amphipathic, cyclic cell-penetrating peptide (CPP). CPP12 binds directly to plasma membrane phospholipids, enters mammalian cells via endocytosis, and then efficiently escapes from endosomes. CPP12 can be used for the intracellular delivery of drugs and chemical probes .
loading...
    loading...
Cat. No.: HY-P10649A
Target:  

Peptides

Research Areas:  

Cancer

CPP12 TFA is a small, amphipathic, cyclic cell-penetrating peptide (CPP). CPP12 TFA binds directly to plasma membrane phospholipids, enters mammalian cells via endocytosis, and then efficiently escapes from endosomes. CPP12 TFA can be used for the intracellular delivery of drugs and chemical probes .
loading...
    loading...
Cat. No.: HY-P11841
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

tP4-CPP12 is a RMI1/2 heterodimer inhibitor with an IC50 of 110 nM. tP4-CPP12 binds competitively at the FANCM-RMI interaction site and disrupts endogenous FANCM-RMI protein-protein interactions. tP4-CPP12 induces antiproliferative effects in ALT-positive osteosarcoma cells. tP4-CPP12 is applicable for the research of ALT-positive osteosarcoma .
loading...
    loading...
Cat. No.: HY-P11856
Research Areas:  

Cancer

cPP12-2-Lys is a cyclic cell-penetrating peptide that serves as a negative control, i.e., it lacks any NatD bisubstrate moiety. cPP12-2-Lys is not a NatD inhibitor (IC50 = 9500 nM), but it possesses excellent cell-penetrating ability and can mediate the entry of conjugated bisubstrate inhibitors into non-small cell lung cancer (NSCLC) cells. cPP12-2-Lys can be used in NSCLC research .
loading...
    loading...